Hyperinsulinemia and the risk of stroke in healthy middle-aged men: The 22-year follow-up results of the Helsinki Policemen Study

Stroke

Volumn 29, Issue 9, 1998, Pages 1860-1866

  Pyörälä, Marja ^b   Miettinen, Heikki ^b   Laakso, Markku ^b   Pyörälä, Kalevi ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b NONE

Author keywords

Epidemiology; Insulin; Risk factors; Stroke onset

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; DISEASE ASSOCIATION; FINLAND; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POLICE; PRIORITY JOURNAL; SKINFOLD THICKNESS; STROKE;

EID: 0345647088     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.9.1860     Document Type: Article

References (44)

1. Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care. 1990; 13:631-654.
2. Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol. 1996;7:217-226.
3. Ruige JB, Assendelft WJJ, Dekker JM, Kostense PJ, Heine RJ, Bouter LM. Insulin and risk of cardiovascular disease: a meta-analysis. Circulation. 1998;97:996-1001.
4. Wingard D, Barrett-Connor E, Ferrara A. Is insulin really a heart disease risk factor? Diabetes Care. 1995;18:1299-1304.
5. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
6. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994;25:1157-1164.
7. Burchfiel CM, Rodriguez BL, Abbott RD, Sharp DS, Curb JD. Insulin levels and risk of stroke. Circulation. 1998;97:824. Abstract.
8. Laakso M, Sarlund H, Salonen R. Pyörälä K, Salonen JT, Karhapää P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.
9. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, and the Atheroslerosis Risk in Communities (ARIC) Study Investigators. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke. 1994;25:66-73.
10. Agewall S, Fagerberg B, Attwall S, Wendelhag I, Urbanovicius V, Wikstrand A. Carotid artery wall thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995;26:956-960.
11. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R, for the IRAS Investigators. Insulin sensitivity and atherosclerosis. Circulation. 1996;93:1809-1817.
12. Pyörälä K. Relationship of glucose tolerance and plasma insulin to incidence of coronary heart disease: results from two population studies from Finland. Diabetes Care. 1979;2:131-141.
13. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 91/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand. 1985;701(suppl):38-52.
14. Pyörälä M, Miettinen H, Laakso M, Pyörälä K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation. 1998;98:398-404.
15. Pyörälä K, Savolainen E, Lehtovirta E, Punsar S, Siltanen P. Glucose tolerance and coronary heart disease: Helsinki Policemen Study. J Chron Dis. 1979;32:729-745.
16. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 1962;27:645-658.
17. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization; 1968.
18. Saltin B, Grimby G, Physiological analysis of middle-aged and old former athletes. Circulation. 1968;38:1104-1115.
19. Åstrand PO, Ryhming I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during submaximal work. J Appl Physiol. 1954;7:218-221.
20. Hyvärinen A, Nikkilä E. Specific determination of blood glucose with o-toluidine. Clin Chim Acta. 1962;7:140-143.
21. Herbert V, Lau KS, Gotlieb CW, Bleicher SJ. Coated charcoal immunoassay of insulin. J Clin Endocrinol. 1965;25:1375-1384.
22. Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952;195:357-366.
23. Björkstén F. Determination of plasma and serum triglycerides with a fully automated method. Clin Chim Acta. 1972;40:143-152.
24. Walker AE, Robins M, Weinfeld FD. The National Survey of stroke: clinical findings. Stroke. 1981;12(suppl I, pt 2):I-13-I-44.
25. Diabetes Melittus: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985. Technical Report Series No. 727.
26. Tuomilehto J, Sarti C, Narva EV, Salmi K, Sivenius J, Kaarsalo E, Salomaa V, Torppa J. The FINMONICA Stroke Register: community-based stroke registration and analysis of stroke incidence in Finland, 1983-1985. Am J Epidemiol. 1992;135:1259-1270.
27. Abbott RD, Yin Y, Reed DM, Yano K. Risk of stroke in male cigarette smokers. N Engl J Med. 1986;315:717-720.
28. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA. 1988;259:1025-1029.
29. Harmsen P, Rosengren A, Tsipogianni A, Wilhelmsen L. Risk factors for stroke in middle-aged men in Göteborg, Sweden. Stroke. 1990;21:223-229.
30. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population. Stroke. 1996;27:210-215.
31. Paffenberger RS, Wing AI. Chronic disease in former college students, XI: early precursors of nonfatal stroke. Am J Epidemiol. 1971;94:524-530.
32. Herman B, Leyten ACM, van Luuk JH, Frenken CWG, Op de Coul AAW, Schulte BPM. An evaluation of risk factors for stroke in a Dutch community. Stroke. 1982;13:334-339.
33. Shinton R, Shipley M, Rose G. Overweight and stroke in the Whitehall Study. J Epidemiol Community Health. 1991;45:138-142.
34. Abbott RD, Behrens GR, Sharp DS, Rodriguez BL, Burcfiel CM, Ross GW, Yano K, Curb JD. Body mass index and thromboembolic stroke in nonsmoking men in older middle age: the Honolulu Heart Program. Stroke. 1994;25:2370-2376.
35. Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. BMJ. 1984;288:1401-1404.
36. Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol. 1996;144:1143-1450.
37. Kannel WB, Cupples LA, Ramaswami R, Stokes J III, Kreger BE, Higgins M. Regional obesity and risk of cardiovascular disease: the Framingham Study. J Clin Epidemiol. 1991;44:183-190.
38. Curb JD, Marcus EB. Body fat, coronary heart disease, and stroke in Japanese men. Am J Clin Nutr. 1991;53:1612S-1615S.
39. Goodpaster BH, Thaete FL, Simoneau J-M, Kelly DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes. 1997;46:1579-1585.
40. Møller LF, Jespersen J. Elevated insulin levels in men: an 11-year follow-up study. J Cardiovasc Risk. 1995;2:339-343.
41. Juhan-Vague I, Alessi MC. PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost. 1997;78:656-660.
42. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG, Walker MK, Alberti KGMM. Serum insulin and incident coronary heart disease in middle-aged men. Am J Epidemiol. 1996;144:224-234.
43. Haffner SM. Cardiovascular risk factors and the prediabetic syndrome. Ann Med. 1996;28:363-370.
44. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol. 1993;137:959-965.